Publications by authors named "Martin Wist"

Claim this Profile
A
Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.
Jialei Qi, Sascha Endres, Deyan Yordanov Yosifov, Eugen Tausch, Rashmi Priyadharshini Dheenadayalan, Martin Wist

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.
Billy Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, Sascha Endres, Philipp M Roessner, Martin Wist

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncatalytic Bruton's tyrosine kinase activates PLCγ variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells.
Martin Wist, Laura Meier, Orit Gutman, Jennifer Haas, Sascha Endres

J Biol Chem· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of phospholipase C-γ mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder.
Claudia Walliser, Martin Wist, Elisabeth Hermkes, Yuan Zhou, Anja Schade

Oncotarget· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cool-temperature-mediated activation of phospholipase C-γ2 in the human hereditary disease PLAID.
Anja Schade, Claudia Walliser, Martin Wist, Jennifer Haas, Petra Vatter

Cell Signal· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis